BioPharma Dive May 3, 2024
Conversations at this year’s J.P. Morgan Healthcare Conference led to a $1 billion buyout that Mariana’s CEO described as a “perfect marriage.”
Mariana Oncology arrived at the J.P. Morgan Healthcare Conference this past January with momentum. The radiopharmaceutical drug developer had secured $175 million in fresh funding four months prior and, in the time since, seen two competitors in its field acquired via multibillion-dollar acquisitions.
The result was a full calendar of meetings for Mariana’s executive team. “The inbound interest was broad and almost frenetic,” said company CEO Simon Read in an interview. “The business development deals in the run-up to J.P. Morgan had really conditioned the marketplace.”
One of those conversations led to Mariana’s own deal, a $1 billion...
Today's Sponsors
Today's Sponsor